Literature DB >> 24201690

Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007.

Jill M Mhyre1, Alexander Shilkrut, Elena V Kuklina, William M Callaghan, Andreea A Creanga, Sari Kaminsky, Brian T Bateman.   

Abstract

OBJECTIVE: To define the frequency, risk factors, and outcomes of massive transfusion in obstetrics.
METHODS: The State Inpatient Dataset for New York (1998-2007) was used to identify all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year. Multivariable logistic regression analysis was performed to examine the relationship between maternal age, race, and relevant clinical variables and the risk of massive blood transfusion defined as 10 or more units of blood recorded.
RESULTS: Massive blood transfusion complicated 6 of every 10,000 deliveries with cases observed even in the smallest facilities. Risk factors with the strongest independent associations with massive blood transfusion included abnormal placentation (1.6/10,000 deliveries, adjusted odds ratio [OR] 18.5, 95% confidence interval [CI] 14.7-23.3), placental abruption (1.0/10,000, adjusted OR 14.6, 95% CI 11.2-19.0), severe preeclampsia (0.8/10,000, adjusted OR 10.4, 95% CI 7.7-14.2), and intrauterine fetal demise (0.7/10,000, adjusted OR 5.5, 95% CI 3.9-7.8). The most common etiologies of massive blood transfusion were abnormal placentation (26.6% of cases), uterine atony (21.2%), placental abruption (16.7%), and postpartum hemorrhage associated with coagulopathy (15.0%). A disproportionate number of women who received a massive blood transfusion experienced severe morbidity including renal failure, acute respiratory distress syndrome, sepsis, and in-hospital death.
CONCLUSION: Massive blood transfusion was infrequent, regardless of facility size. In the presence of known risk for receipt of massive blood transfusion, women should be informed of this possibility, should deliver in a well-resourced facility if possible, and should receive appropriate blood product preparation and venous access in advance of delivery. LEVEL OF EVIDENCE: : II.

Entities:  

Mesh:

Year:  2013        PMID: 24201690      PMCID: PMC4547558          DOI: 10.1097/AOG.0000000000000021

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

1.  Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products.

Authors:  Laurence E Shields; Kathy Smalarz; Lester Reffigee; Sandra Mugg; Theodore J Burdumy; Marilyn Propst
Journal:  Am J Obstet Gynecol       Date:  2011-06-29       Impact factor: 8.661

2.  The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries.

Authors:  Brian T Bateman; Mitchell F Berman; Laura E Riley; Lisa R Leffert
Journal:  Anesth Analg       Date:  2010-03-17       Impact factor: 5.108

3.  Trends in postpartum hemorrhage: United States, 1994-2006.

Authors:  William M Callaghan; Elena V Kuklina; Cynthia J Berg
Journal:  Am J Obstet Gynecol       Date:  2010-04       Impact factor: 8.661

4.  Regionalization of care for obstetric hemorrhage and its effect on maternal mortality.

Authors:  Jason D Wright; Thomas J Herzog; Monjri Shah; Clarissa Bonanno; Sharyn N Lewin; Kirsten Cleary; Lynn L Simpson; Sreedhar Gaddipati; Xuming Sun; Mary E D'Alton; Patricia Devine
Journal:  Obstet Gynecol       Date:  2010-06       Impact factor: 7.661

5.  An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity.

Authors:  Elena V Kuklina; Maura K Whiteman; Susan D Hillis; Denise J Jamieson; Susan F Meikle; Samuel F Posner; Polly A Marchbanks
Journal:  Matern Child Health J       Date:  2007-08-10

Review 6.  The retained placenta: historical and geographical rate variations.

Authors:  W M C Cheung; A Hawkes; S Ibish; A D Weeks
Journal:  J Obstet Gynaecol       Date:  2011       Impact factor: 1.246

7.  Abnormal placentation: twenty-year analysis.

Authors:  Serena Wu; Masha Kocherginsky; Judith U Hibbard
Journal:  Am J Obstet Gynecol       Date:  2005-05       Impact factor: 8.661

8.  Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care.

Authors:  Alexandra G Eller; Michele A Bennett; Margarita Sharshiner; Carol Masheter; Andrew P Soisson; Mark Dodson; Robert M Silver
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

9.  Severe obstetric morbidity in the United States: 1998-2005.

Authors:  Elena V Kuklina; Susan F Meikle; Denise J Jamieson; Maura K Whiteman; Wanda D Barfield; Susan D Hillis; Samuel F Posner
Journal:  Obstet Gynecol       Date:  2009-02       Impact factor: 7.661

Review 10.  Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group.

Authors:  Marian Knight; William M Callaghan; Cynthia Berg; Sophie Alexander; Marie-Helene Bouvier-Colle; Jane B Ford; K S Joseph; Gwyneth Lewis; Robert M Liston; Christine L Roberts; Jeremy Oats; James Walker
Journal:  BMC Pregnancy Childbirth       Date:  2009-11-27       Impact factor: 3.007

View more
  24 in total

1.  Incidence and risk factors of transfusion reactions in postpartum blood transfusions.

Authors:  Lars Thurn; Agneta Wikman; Magnus Westgren; Pelle G Lindqvist
Journal:  Blood Adv       Date:  2019-08-13

Review 2.  Maternal, Labor, Delivery, and Perinatal Outcomes Associated with Placental Abruption: A Systematic Review.

Authors:  Katheryne L Downes; Katherine L Grantz; Edmond D Shenassa
Journal:  Am J Perinatol       Date:  2017-03-22       Impact factor: 1.862

Review 3.  Transfusion and coagulation management in major obstetric hemorrhage.

Authors:  Alexander J Butwick; Lawrence T Goodnough
Journal:  Curr Opin Anaesthesiol       Date:  2015-06       Impact factor: 2.706

Review 4.  Clinical Approach to and Work-up of Bleeding Patients.

Authors:  Shantanu Warhadapande; Sean R Dariushnia; Nima Kokabi; William G O'Connell; Janice M Newsome; Laura K Findeiss; Bill S Majdalany
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

5.  Second-line uterotonics and the risk of hemorrhage-related morbidity.

Authors:  Alexander J Butwick; Brendan Carvalho; Yair J Blumenfeld; Yasser Y El-Sayed; Lorene M Nelson; Brian T Bateman
Journal:  Am J Obstet Gynecol       Date:  2015-01-09       Impact factor: 8.661

6.  Assessing the Accuracy of Reporting of Maternal Red Blood Cell Transfusion at Birth Reported in Routinely Collected Hospital Data.

Authors:  Jillian A Patterson; Sally Francis; Jane B Ford
Journal:  Matern Child Health J       Date:  2016-09

7.  Risk Factors for Severe Postpartum Hemorrhage After Cesarean Delivery: Case-Control Studies.

Authors:  Alexander J Butwick; Bharathi Ramachandran; Priya Hegde; Edward T Riley; Yasser Y El-Sayed; Lorene M Nelson
Journal:  Anesth Analg       Date:  2017-08       Impact factor: 5.108

8.  Risk for postpartum hemorrhage, transfusion, and hemorrhage-related morbidity at low, moderate, and high volume hospitals.

Authors:  Audrey A Merriam; Jason D Wright; Zainab Siddiq; Mary E D'Alton; Alexander M Friedman; Cande V Ananth; Brian T Bateman
Journal:  J Matern Fetal Neonatal Med       Date:  2017-04-03

Review 9.  National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review.

Authors:  Ruth Shaylor; Carolyn F Weiniger; Naola Austin; Alexander Tzabazis; Aryeh Shander; Lawrence T Goodnough; Alexander J Butwick
Journal:  Anesth Analg       Date:  2017-01       Impact factor: 5.108

10.  Obstetric interventions and maternal morbidity among women who experience severe postpartum hemorrhage during cesarean delivery.

Authors:  K Seligman; B Ramachandran; P Hegde; E T Riley; Y Y El-Sayed; L M Nelson; A J Butwick
Journal:  Int J Obstet Anesth       Date:  2017-03-22       Impact factor: 2.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.